| SQ109 |
| N-[(2E)-3,7-Dimethyl-2,6-octadienyl]-N’-tricyclo[3.3.1.1(3,7)]dec-2-yl-1,2-ethanediamine |
| (CAS 502487-67-4) |
 |
| Description： |
SQ109 is an orally active, small molecule antibiotic for treatment of pulmonary T(tuberculosis).
In Phase I clinical trials, SQ109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen. SQ109 has excellent in vitro activity against Mycobacterium tuberculosis within a MIC range of 1-0.5 μM (drug susceptible) and drug resistant TB bacteria, including XDR-TB, as well as potent in vivo activity against pulmonary TB alone and with other TB drugs.
|
| Product No. |
KT00844 |
| Product Name |
SQ109 |
| Synonyms |
NSC 722041 |
| Formal Name |
N-[(2E)-3,7-Dimethyl-2,6-octadienyl]-N’-tricyclo[3.3.1.1(3,7)]dec-2-yl-1,2-ethanediamine |
| CAS Number |
502487-67-4 |
| Molecular Formula |
C22H38N2 |
| Formula Weight |
330.55 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
(S)-Tedizolid
5-hydroxypyrazine-2-carboxylic acid
Actinomycin D
AHAS inhibitor
Amikacin
Amikacin hydrate
Amoxicillin
Amoxicillin sodium
Amoxicillin trihydrate
|
|
